proteína de garbanzo

Condiciones de salud que proteína de garbanzo puede ayudar a apoyar.

• DispepsiaCientífico

  Chickpeas are a significant source of non-heme iron, folate, and vitamin B6—micronutrients essential for erythropoiesis. Dietary studies and some clinical trials report improved haemoglobin levels and anemia markers with chickpea-enriched diets, particularly in nutritionally at-risk populations. Bioavailability of iron is limited by phytates but can be enhanced when co-consumed with vitamin C-rich foods.

• HipocondríaCientífico

  Chickpea protein hydrolysates exhibit significant in vitro antioxidant activity, and in vivo studies in mice confirm antioxidant effects of specific chickpea protein fractions. Phenolic compounds, flavonoids, and selenium present in chickpeas contribute to antioxidant capacity alongside the protein-derived peptides.

• AcnéCientífico

  Clinical trials demonstrate that chickpea consumption increases subjective satiety and reduces energy intake at subsequent meals compared to wheat-based or potato controls. The high protein and resistant starch content slows gastric emptying and blunts post-meal hunger signals. Controlled crossover studies in healthy adults document these effects across multiple chickpea forms.

• HipotensiónCientífico

  Chickpea protein hydrolysates contain ACE-I inhibitory peptides that reduce blood pressure in preclinical models. An optimised alcalase-generated chickpea hydrolysate reduced systolic blood pressure by up to 47.35 mmHg in spontaneously hypertensive rats at 50 mg/kg. Human RCTs evaluating isolated chickpea peptides for hypertension have not yet been published.

• Fatiga SuprarrenalCientífico

  A 2025 systematic review and meta-analysis of 28 controlled trials found chickpea consumption significantly reduced postprandial glucose incremental AUC versus carbohydrate-matched controls (MD: −47.89, p<0.0001). The protein and resistant starch in chickpeas inhibit α-glucosidase and slow intestinal glucose absorption. Evidence certainty is low to very low due to heterogeneity across studies.

• Válvula IleocecalCientífico

  Chickpea dietary supplementation produces small but statistically significant reductions in total cholesterol and LDL-C in clinical trials. A 12-week RCT in prediabetic adults found LDL-C fell from 131.9 to 119.3 mg/dL versus baseline in the chickpea arm. A meta-analysis of 11 clinical trials confirmed that chickpea consumption significantly reduces LDL cholesterol.

• ApendicitisCientífico

  Chickpea consumption is associated with reductions in inflammatory markers including high-sensitivity CRP. A 12-week RCT found hsCRP decreased from 5 mg/L to 3.5 mg/L at week 6 in the chickpea group. Chickpea protein hydrolysates exhibit anti-inflammatory properties in preclinical models by modulating inflammatory gene expression in liver and adipose tissue.

• ArtritisCientífico

  Dietary fibre from chickpeas acts as a bulk-forming agent that promotes bowel regularity. Clinical trial participants consuming chickpeas reported improved bowel function and increased stool frequency. The fibre content of chickpeas meets or exceeds that of other pulses, contributing to the prebiotic and laxative effects observed in controlled studies.

• Olor CorporalCientífico

  Chickpea protein and resistant starch stimulate secretion of gut incretin hormones including GLP-1 and PYY, which regulate glucose homeostasis and satiety. A randomised crossover study found enhanced secretion of satiety-promoting gut hormones in humans consuming white bread enriched with cellular chickpea flour. Fermentation of chickpea fibre in the colon produces SCFAs that further upregulate GLP-1.

• Leche materna (secar)Científico

  Chickpea fibre and protein serve as prebiotic substrates, fermenting in the colon to produce SCFAs and selectively enriching beneficial microbial populations. Preclinical studies show chickpea-supplemented diets alter gut microbiome composition and enhance gut barrier integrity. A registered human RCT is actively evaluating 8 weeks of chickpea intake on microbiome diversity, metabolome, and gut barrier function.

• Moretones (prevención)Científico

  Chickpea protein supplementation in ad libitum diets is associated with reduced spontaneous energy intake and modest improvements in body weight management. The satiating effect of chickpea protein slows gastric emptying and raises anorexigenic hormone levels. A chickpea protein hydrolysate attenuated weight gain and modulated inflammation markers in a high-fat-diet mouse model.

• JuanetesCientífico

  Multiple clinical trials and a systematic review document that chickpea consumption reduces total cholesterol, LDL-C, and high-sensitivity CRP—key cardiovascular risk factors. A 12-week RCT in people with prediabetes showed total cholesterol fell from 200.4 to 185.8 mg/dL and LDL-C from 131.9 to 119.3 mg/dL in the chickpea group. ACE-inhibitory peptides derived from chickpea protein may additionally lower blood pressure.

• Olor de piesCientífico

  Chickpea protein hydrolysates contain DPP-IV inhibitory peptides that preserve active GLP-1, supporting insulin secretion and peripheral glucose uptake. Controlled diet studies demonstrate decreased plasma insulin concentration with chickpea supplementation. Colonic fermentation of chickpea fibre produces SCFAs that enhance insulin sensitivity at the hepatic and peripheral level.

• GingivitisCientífico

  Chickpea protein and whole chickpeas address multiple components of metabolic syndrome simultaneously, including elevated blood glucose, dyslipidaemia, and inflammation. A high-fat-diet murine study with chickpea protein hydrolysate demonstrated amelioration of obesity-induced metabolic markers. Human clinical trials show concurrent improvements in cholesterol, glycaemia, and CRP in at-risk populations.

Sistemas corporales que proteína de garbanzo puede ayudar a apoyar.

• No hay sistemas corporales disponibles.